TNFRSF1A and cancer: Although TNFR2 blockade can divert cancer cells from a survival pathway, agonist molecules may cause a domino effect that could sensitize malignant cells to TNFR1-induced cell death by depriving them of cIAP/TRAF (Siegmund et al., 2016).